Lazard Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,993
Closed -$414K 2083
2026
Q1
$414K Sell
6,993
-16,299
-70% -$1.06M ﹤0.01% 1434
2025
Q4
$1.44M Sell
23,292
-226
-1% -$13.8K ﹤0.01% 1031
2025
Q3
$1.47M Sell
23,518
-17,483
-43% -$1.22M ﹤0.01% 988
2025
Q2
$3.27M Sell
41,001
-47,047
-53% -$3.94M ﹤0.01% 858
2025
Q1
$7.57M Sell
88,048
-445
-0.5% -$36.5K 0.01% 554
2024
Q4
$6.91M Buy
88,493
+15,996
+22% +$1.24M 0.01% 556
2024
Q3
$5.23M Buy
72,497
+71,211
+5,537% +$5.04M 0.01% 621
2024
Q2
$88K Hold
1,286
﹤0.01% 1787
2024
Q1
$93K Sell
1,286
-75
-6% -$5.01K ﹤0.01% 1557
2023
Q4
$83K Hold
1,361
﹤0.01% 1735
2023
Q3
$77K Hold
1,361
﹤0.01% 1719
2023
Q2
$80K Sell
1,361
-14,226
-91% -$851K ﹤0.01% 1665
2023
Q1
$976K Sell
15,587
-18,313
-54% -$1.14M ﹤0.01% 1019
2022
Q4
$2.12M Sell
33,900
-2,829
-8% -$162K ﹤0.01% 895
2022
Q3
$1.83M Buy
36,729
+15,629
+74% +$865K ﹤0.01% 909
2022
Q2
$1.24M Buy
21,100
+21,076
+87,817% +$1.16M ﹤0.01% 978
2022
Q1
$1K Buy
+24
New +$1.39K ﹤0.01% 2289
2020
Q4
Sell
-711
Closed -$25K 1944
2020
Q3
$25K Sell
711
-707
-50% -$26.3K ﹤0.01% 1376
2020
Q2
$53K Buy
+1,418
New +$56.7K ﹤0.01% 1214

Other funds holding PBH

Lazard Asset Management's PBH Position: Q2 2026 in Review

Lazard Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 6,993 shares — an estimated $414K sold.

Lazard Asset Management first reported a position in PBH in Q2 2020 and held it in 19 quarters. The position peaked at $7.57M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Lazard Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 6,993 Prestige Consumer Healthcare shares in Q2 2026, an estimated $414K.
  • Lazard Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 19 quarters.
  • Lazard Asset Management's Prestige Consumer Healthcare position peaked at $7.57M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.